NASDAQ: ALKS) that Alkermes
had filed a lawsuit in U.
DUBLIN -- Alkermes
plc (NASDAQ: ALKS) and Elan Corporation, plc (NYSE: ELN) ("Elan") today announced the completion of the merger between Alkermes
restructured its joint development program with Alkermes
NASDAQ: ALKS) today announced that Alkermes
shareholders have approved the merger of Alkermes
and Elan Drug Technologies ("EDT"), the profitable drug formulation and manufacturing business unit of Elan Corporation, plc (NYSE: ELN) ("Elan").
ANNOUNCES INTERIM RESULTS OF PHASE 1B TRIAL
This increase in revenues was offset in part by loss of contract revenues which resulted from the termination of a research and development agreement with Alkermes
Investment Partners, L.
is developing RMPs to be used in conjunction with therapeutic compounds for the treatment of infectious diseases of the central nervous system and brain tumor.
Graney comes to Alkermes
from Rhone-Poulenc Rorer, Collegeville, Pa.
is an exciting company and David leaves it in a strong position as we prepare for the approval of exenatide once weekly, complete the VIVITROL([R]) pivotal study to expand the label into the opioid dependence indication and expand our pipeline of innovative medicines," said Richard Pops.
warrants to purchase up to 2,948,600 shares of Alkermes
is also providing a podcast MP3 file available for download on the Alkermes
website, which will be available shortly following the conference call and will be available until Thursday, November 13, 2008.
AND CORTEX TO COLLABORATE ON STROKE TREATMENT